-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide
The population
at high risk of severe disease was further clarified.
Source: National Health Commission official website
On January 13, the National Health Commission issued the "Diagnosis and Treatment Plan for Severe Disease of Novel Coronavirus Infection (Trial Fourth Edition)", which further clarifies that patients at high risk of severe disease can be managed as severe cases for patients with new coronavirus infection pneumonia who do not meet the diagnostic criteria for severe disease, but are > 65 years old, have not completed full vaccination, and have more serious chronic diseases
.
(